Publisher
Public Library of Science (PLoS)
Reference47 articles.
1. Genetic advances in systemic lupus erythematosus: an update;L Chen;Curr Opin Rheumatol,2017
2. Anifrolumab, an Anti-Interferon-alpha Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus;R Furie;Arthritis Rheumatol,2017
3. Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study;RF van Vollenhoven;Lancet,2018
4. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial;DJ Wallace;Lancet,2018
5. A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus [cited 2019 06-17-2019]. Available from: https://clinicaltrials.gov/ct2/show/NCT03517722.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献